Biotechnology Stocks II Performance Guide: Taysha Gene Therapies, Inc. (TSHA)
TSHA has no dividends.
Table and Chart of TSHA Performance
See what a $1,000 investment in TSHA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| TSHA Returns | |
|---|---|
| Start Date | Oct-30-2020 |
| Start Price | $20.80 |
| End Date | May-16-2024 |
| End Price | $3.14 |
| # Prices | 44 |
| Min Date | Jun-30-2023 |
| Min Price | $0.66 |
| Max Date | Dec-31-2020 |
| Max Price | $26.54 |
| Total Return | -84.90% |
| Annualized Return | -40.29% |
| Current Value of $1,000 Purchase | $151 |
| Number Returns | 946 |
| Average Return | -37.08% |
| Number Profitable Returns | 154 |
| Percent Profitable Returns | 16.28% |
| Number Unprofitable Returns | 792 |
| Percent Unprofitable Returns | 83.72% |
| Profitable to Unprofitable Returns Ratio | 0.19 |
| TSHA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $581,626,000 |
| Beta | 0.348 | Price to Sales | 35.59 |
| Earnings per Share | $-0.9600 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 7.32 |
| PRICE DATA | |
| 52 Week High | $3.89 |
| 52 Week Low | $0.5 |
| Analyst Target Price | $6.95 |
| 50-Day Moving Average | $2.615 |
| 200-Day Moving Average | $2.214 |
| FINANCIAL DATA | |
| Revenue per Share | $0.133 |
| Revenue | $15,451,000 |
| Profit Margin | 0% |
| Return on Equity | -294% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
TSHA Compare Returns with S&P 500
TSHA Trendline Chart
TSHA Moving Average Chart
TSHA Stock Return Map - See Patterns of Gains and Losses
TSHA Stock Returns/Purchase Dates